Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-08-22 Benathen Marc David Chief Financial Officer Grant or award +87,000 426,554
2025-06-17 Benathen Marc David Chief Financial Officer Sale 10b5-1 −50,000 $14.01 $700K 339,554
2025-06-16 Benathen Marc David Chief Financial Officer Sale 10b5-1 −75,000 $13.09 $982K 389,554
2025-03-31 Benathen Marc David Chief Financial Officer Grant or award +75,000 464,554
2025-03-07 Benathen Marc David Chief Financial Officer Grant or award +87,000 389,554
2024-03-21 Benathen Marc David Chief Financial Officer Grant or award +75,000 302,554
2023-07-11 Benathen Marc David Chief Financial Officer Grant or award +125,000 202,554
2023-07-11 Benathen Marc David Chief Financial Officer Exercise or conversion +25,000 227,554
2023-07-11 Benathen Marc David Chief Financial Officer Returned to the company · Employee Stock Option (Right to Buy) −200,000 0
2023-07-11 Benathen Marc David Chief Financial Officer Exercise or conversion · Restricted Stock −25,000 0
2023-01-27 Benathen Marc David Chief Financial Officer Exercise or conversion +25,000 77,554
2023-01-27 Benathen Marc David Chief Financial Officer Exercise or conversion · Restricted Stock −25,000 25,000
2022-01-27 Benathen Marc David Chief Financial Officer Exercise or conversion +25,000 52,554
2022-01-27 Benathen Marc David Chief Financial Officer Grant or award · Restricted Stock Unit +75,000 75,000
2022-01-27 Benathen Marc David Chief Financial Officer Exercise or conversion · Restricted Stock Unit −25,000 50,000
2021-11-30 Benathen Marc David Chief Financial Officer Purchase +7,831 $4.09 $32K 27,554
2021-08-18 Benathen Marc David Chief Financial Officer Purchase +1,297 $7.23 $9K 17,953
2021-08-18 Benathen Marc David Chief Financial Officer Purchase +1,300 $7.26 $9K 19,253
2021-08-18 Benathen Marc David Chief Financial Officer Purchase +64 $7.29 $467 19,317
2021-08-18 Benathen Marc David Chief Financial Officer Purchase +63 $7.24 $456 19,380

Page 1 of 2 · 23 trades